The dawn and evolution of immunotherapies have given rise to a new class of cancer survivors whose novel experience with these treatments require new tools and resources in survivorship. However, these patients are not typical candidates for receiving traditional survivorship care plans or resources. Current Commission on Cancer standards do not require cancer programs and practices to provide survivorship services to patients treated with immunotherapies. But the survivorship needs of these patients are many and unique. In particular, managing potential toxicities during and beyond treatment requires coordinated care among multiple providers that is essential for positive outcomes.
How to use these resources:
The resources linked to this page are intended to be à la cart; look around and take the tools that most fit your program’s needs:
These templates are also available in Spanish and Mandarin.
Be sure to also check out our additional resources on immunotherapies for more context on the development of these tools and how to best use them.
